Boryung Pharmaceutical Invests 24 Billion KRW in U.S. Local Corporation

[Asia Economy Reporter Minji Lee] Boryung Pharmaceutical announced on the 30th that it will invest 24 billion KRW in its local US corporation (Hayan I, L.P.). The investment amount corresponds to 8.5% of its equity capital.

Boryung Pharmaceutical stated, "This is to secure global investment opportunities and enhance the possibility of expanding business areas through investment in a US fund."